XML 41 R19.htm IDEA: XBRL DOCUMENT

Restatement of Previously Issued Financial Statements (Tables)

5 Months Ended

Dec. 31, 2020

Condensed Financial Information Disclosure [Abstract]

Condensed Balance Sheet [Table Text Block]

		As of December 31, 2020
		As Previously Reported				Restatement Adjustment				As Restated
Balance Sheet
Total assets		$	376,272,470			$	—			$	376,272,470
Liabilities and Shareholders’ Equity
Total current liabilities		$	122,735			$	—			$	122,735
Deferred underwriting commissions			13,125,000				—				13,125,000
Derivative warrant liabilities			—				28,500,590				28,500,590
Total liabilities			13,247,735				28,500,590				41,748,325
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption			358,024,730				(28,500,590	)			329,524,140
Shareholders’ equity
Preference shares – $0.0001 par value			—				—				—
Class A ordinary shares – $0.0001 par value			170				285				455
Class B ordinary shares – $0.0001 par value			937				—				937
Additional paid-in-capital			5,351,344				6,321,420				11,672,764
Accumulated deficit			(352,446	)			(6,321,705	)			(6,674,151	)
Total shareholders’ equity			5,000,005				—				5,000,005
Total liabilities and shareholders’ equity		$	376,272,470				—			$	376,272,470

		As of October 9, 2020
		As Previously Reported				Restatement Adjustment				As Restated
Balance Sheet
Total assets		$	351,797,538			$	—			$	351,797,538
Liabilities and shareholders’ equity
Total current liabilities		$	327,799			$	—			$	327,799
Deferred underwriting commissions			12,250,000				—				12,250,000
Derivative warrant liabilities			—				21,616,670				21,616,670
Total liabilities			12,577,799				21,616,670				34,194,469
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption			334,219,730				(21,616,670	)			312,603,060
Shareholders’ equity
Preference shares – $0.0001 par value			—				—				—
Class A ordinary shares – $0.0001 par value			158				216				374
Class B ordinary shares – $0.0001 par value			1,006				—				1,006
Additional paid-in-capital			5,038,954				806,726				5,845,680
Accumulated deficit			(40,109	)			(806,942	)			(847,051	)
Total shareholders’ equity			5,000,009				—				5,000,009
Total liabilities and shareholders’ equity		$	351,797,538				—			$	351,797,538

Condensed Income Statement [Table Text Block]

		Period From July 29, 2020 (Inception) Through December 31, 2020
		As Previously Reported				Restatement Adjustment				As Restated
Statement of Operations and Comprehensive Loss
Loss from operations		$	(360,420	)		$	—			$	(360,420	)
Other (expense) income:
Change in fair value of derivative warrant liabilities			—				(5,458,920	)			(5,458,920	)
Financing cost – derivative warrant liabilities							(862,785	)			(862,785	)
Net gain from cash equivalents held in Trust Account			7,974				—				7,974
Total other (expense) income			7,974				(6,321,705	)			(6,313,731	)
Net loss		$	(352,446	)		$	(6,321,705	)		$	(6,674,151	)
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted			35,001,205				(2,169,862	)			32,831,343
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption		$	—				—			$	—
Weighted average shares outstanding of non-redeemable ordinary shares, basic and diluted			9,819,148				1,183,561				11,002,709
Basic and diluted net loss per share, non-redeemable ordinary shares		$	(0.04	)		$	(0.57	)		$	(0.61	)

Condensed Cash Flow Statement [Table Text Block]

		Period From July 29, 2020 (Inception) Through December 31, 2020
		As Previously Reported				Restatement Adjustment				As Restated
Statement of Cash Flows
Net loss		$	(352,446	)		$	(6,321,705	)		$	(6,674,151	)
Adjustment to reconcile net loss to net cash used in operating activities			(373,404	)			5,458,920				5,085,516
Net cash used in operating activities			(725,850	)			—				(725,850	)
Net cash used in investing activities			(375,000,000	)			—				(375,000,000	)
Net cash provided by financing activities			376,547,181				—				376,547,181
Net change in cash		$	821,331			$	—			$	821,331